US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ming Shing Group Holdings Limited

1.37

-0.0800-5.52%

Post-market: 1.36-0.0150-1.09%18:35 EDT

Volume:11.75K

Turnover:16.37K

Market Cap:17.78M

PE:-1.69

High:1.44

Open:1.44

Low:1.36

Close:1.45

52wk High:3.15

52wk Low:0.6000

Shares:12.98M

Float Shares:12.98M

Volume Ratio:0.13

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8129

EPS(LYR):-0.4836

ROE:--

ROA:-65.10%

PB:-6.78

PE(LYR):-2.83

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

GRAIL (GRAL) Is Down 6.5% After FDA Sets Galleri PMA Panel Review – Has The Bull Case Changed?

Simply Wall St.

Ming Shing Group Holdings Limited Announces Receipt of NASDAQ Notice Regarding Minimum Stockholders’ Equity Requirement

Ming Shing FY26 Net Loss Widens to USD 5.76 Million; Revenue Drops 56.8% to USD 14.63 Million

Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PMA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PMA\",,,,,undefined,":{"symbol":"PMA","market":"US","secType":"STK","nameCN":"Ming Shing Group Holdings Limited","latestPrice":1.37,"timestamp":1787342400000,"preClose":1.45,"halted":0,"volume":11745,"hourTrading":{"tag":"盘后","latestPrice":1.355,"preClose":1.37,"latestTime":"18:35 EDT","volume":211,"amount":285.99,"timestamp":1787351714044,"change":-0.015,"changeRate":-0.010949,"amplitude":0.010949},"delay":0,"changeRate":-0.05517241379310334,"floatShares":12975000,"shares":12975000,"eps":-0.812882,"marketStatus":"Market Closed","change":-0.08,"latestTime":"08-21 16:00:00 EDT","open":1.44,"high":1.44,"low":1.36,"amount":16371.969763500001,"amplitude":0.055172,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.812882,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1718942400000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.45,"latestTime":"09:28 EDT","volume":247,"amount":344.2999937,"timestamp":1787318919418,"change":-0.03,"changeRate":-0.02069,"amplitude":0.041379},"postHourTrading":{"tag":"盘后","latestPrice":1.355,"preClose":1.37,"latestTime":"18:35 EDT","volume":211,"amount":285.99,"timestamp":1787351714044,"change":-0.015,"changeRate":-0.010949,"amplitude":0.010949},"volumeRatio":0.1289107605630277},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PMA\",,,,,undefined,":{"symbol":"PMA","floatShares":12975000,"roa":"-65.10%","roe":"--","lyrEps":-0.483641,"volumeRatio":0.1289107605630277,"shares":12975000,"dividePrice":0,"high":1.44,"amplitude":0.055172,"preClose":1.45,"low":1.36,"week52Low":0.6,"pbRate":"-6.78","psRate":"0.71","week52High":3.15,"institutionHeld":0,"latestPrice":1.37,"eps":-0.812882,"divideRate":0,"volume":11745,"delay":0,"ttmEps":-0.812882,"open":1.44,"prevYearClose":1,"prevWeekClose":1.73,"prevMonthClose":1.31,"prevQuarterClose":1.33,"fiveDayClose":1.73,"twentyDayClose":1.28,"sixtyDayClose":1.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-20","symbol":"PMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1773979200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-08-15","symbol":"PMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755230400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PMA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PMA","date":"2026-08-21","current":-1.685361,"percent":0.206897,"low":-2.175107,"twenty":-1.835639,"median":-1.709911,"eighty":-1.581667,"high":-1.496172,"avg":-1.737361,"sd":0.169931,"marketCap":18813750},"quantilePoints":[{"date":"2026-07-10","current":-1.6219,"twenty":-1.6219,"median":-1.6219,"eighty":-1.6219,"marketCap":16737750},{"date":"2026-07-17","current":-1.709911,"twenty":-1.885931,"median":-1.722483,"eighty":-1.709911,"marketCap":17646000},{"date":"2026-07-24","current":-1.647046,"twenty":-1.823066,"median":-1.760202,"eighty":-1.709911,"marketCap":16997250},{"date":"2026-07-31","current":-1.571609,"twenty":-1.80295,"median":-1.722483,"eighty":-1.581667,"marketCap":16218750},{"date":"2026-08-07","current":-1.672192,"twenty":-1.777804,"median":-1.691051,"eighty":-1.571609,"marketCap":17256750},{"date":"2026-08-14","current":-2.036805,"twenty":-1.777804,"median":-1.647046,"eighty":-1.571609,"marketCap":21019500},{"date":"2026-08-21","current":-1.823066,"twenty":-1.835639,"median":-1.709911,"eighty":-1.581667,"marketCap":18813750}],"updateTime":1787456187302},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PMA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660084498","title":"GRAIL (GRAL) Is Down 6.5% After FDA Sets Galleri PMA Panel Review – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660084498","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660084498?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:28","pubTimestamp":1787059732,"startTime":"0","endTime":"0","summary":"GRAIL announced that the FDA’s Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review the Premarket Approval application for its Galleri multi-cancer early detection blood test, which targets cancer-specific methylation patterns and is intended to complement existing screening methods.\nThis review marks a major regulatory inflection point for what GRAIL describes as the only multi-cancer early detection test backed by large interventional and randomized, controlled...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-down-65-after-fda-sets-galleri-pma-panel-revie","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/grail-gral-is-down-65-after-fda-sets-galleri-pma-panel-revie","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4139","GRAL","BK4129","PMA","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660621164","title":"Ming Shing Group Holdings Limited Announces Receipt of NASDAQ Notice Regarding Minimum Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660621164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660621164?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:16","pubTimestamp":1787055384,"startTime":"0","endTime":"0","summary":"BRIEF-Ming Shing Group Holdings Limited Announces Receipt Of Nasdaq Notice Regarding Minimum Stockholders’ Equity RequirementMing Shing Group Holdings LtdPMA.O:MING SHING GROUP HOLDINGS LIMITED ANNOUN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUAB6NPDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","PMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448135","title":"Ming Shing FY26 Net Loss Widens to USD 5.76 Million; Revenue Drops 56.8% to USD 14.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448135","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448135?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:22","pubTimestamp":1786962144,"startTime":"0","endTime":"0","summary":"Ming Shing FY26 net loss widens to USD 5.76 million; revenue drops 56.8% to USD 14.63 millionMing Shing posted a net loss of USD 5.76 million, up 0.6% from the prior fiscal year.Revenue fell 56.8% to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL78CGlw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","PMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659385900","title":"Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659385900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659385900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"AKI, adding 3 new customers from top-rated children's hospitals, bringing. the total customer base to 20 and building increased depth in customer. orders. This led to second quarter 2026 net revenue of $0.6 million for. QUELIMMUNE product sales, an increase of 82% versus the second quarter of. -- Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial. evaluating the SCD therapy as a potential treatment of adult patients. with AKI in the ICU receiving continuous renal replacement therapy. The. trial has enrolled 223 of 339 patients to date. Completion of enrollment. is anticipated around year end or into the first quarter of 2027, which. would enable a PMA application to the FDA near the end of 2027, pending a. -- Received from the Centers for Medicare & Medicaid Services ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4208","LU1003077747.HKD","BK4082","LU2500361329.USD","CMS","LU2346227817.USD","LU0949170772.SGD","LU0545039389.USD","LU0738911758.USD","BK4588","LU0661504455.SGD","BK4129","LU1894683264.USD","BK4585","LU0553294199.USD","BK4022","LU1894683348.USD","ICU","R","SCD","LU2637428348.USD","BK4232","PMA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PMA\",params:#limit:6,delay:false,,,undefined,":[]}}